FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:136-138 January 9, 1997 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by The EPIC Investigators Related Article by The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

To the Editor: The Bypass Angioplasty Revascularization Investigation (BARI) investigators (July 25 issue)¹ reported the five-year clinical results of a trial comparing coronary-artery bypass grafting (CABG) with percutaneous transluminal coronary angioplasty (PTCA) in patients with multivessel disease. The study tested the hypothesis that in patients with multivessel disease and severe angina or ischemia, an initial revascularization strategy involving PTCA does not result in a poorer clinical outcome than CABG during a five-year follow-up period. Although all the patients in the study had clinically severe angina or objective evidence of ischemia, the incidence of these events after the procedures was not . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.